These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 9821555)

  • 1. Effect of chronic nicotine on brain stimulation reward. II. An escalating dose regimen.
    Bozarth MA; Pudiak CM; KuoLee R
    Behav Brain Res; 1998 Nov; 96(1-2):189-94. PubMed ID: 9821555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of chronic nicotine on brain stimulation reward. I. Effect of daily injections.
    Bozarth MA; Pudiak CM; KuoLee R
    Behav Brain Res; 1998 Nov; 96(1-2):185-8. PubMed ID: 9821554
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Withdrawal from repeated nicotine vapor exposure increases somatic signs of physical dependence, anxiety-like behavior, and brain reward thresholds in adult male rats.
    Martínez M; Espinoza VE; Garcia V; Uribe KP; Negishi K; Estevao IL; Carcoba LM; O'Dell LE; Khan AM; Mendez IA
    Neuropharmacology; 2023 Dec; 240():109681. PubMed ID: 37611823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship Between Nicotine Intake and Reward Function in Rats With Intermittent Short Versus Long Access to Nicotine.
    Geste JR; Levin B; Wilks I; Pompilus M; Zhang X; Esser KA; Febo M; O'Dell L; Bruijnzeel AW
    Nicotine Tob Res; 2020 Feb; 22(2):213-223. PubMed ID: 30958557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats.
    Bruijnzeel AW; Markou A
    Brain Res; 2005 Oct; 1058(1-2):91-100. PubMed ID: 16126181
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of effects produced by nicotine and the α4β2-selective agonist 5-I-A-85380 on intracranial self-stimulation in rats.
    Freitas K; Carroll FI; Negus SS
    Exp Clin Psychopharmacol; 2016 Feb; 24(1):65-75. PubMed ID: 26461167
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rewarding Effects of Nicotine in Adolescent and Adult Male and Female Rats as Measured Using Intracranial Self-stimulation.
    Xue S; Behnood-Rod A; Wilson R; Wilks I; Tan S; Bruijnzeel AW
    Nicotine Tob Res; 2020 Feb; 22(2):172-179. PubMed ID: 30452710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
    Zeeb FD; Higgins GA; Fletcher PJ
    ACS Chem Neurosci; 2015 Jul; 6(7):1231-40. PubMed ID: 25781911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicotine on the threshold for rewarding brain stimulation in rats.
    Huston-Lyons D; Kornetsky C
    Pharmacol Biochem Behav; 1992 Apr; 41(4):755-9. PubMed ID: 1594644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolonged nicotine exposure does not alter GABA(B) receptor-mediated regulation of brain reward function.
    Paterson NE; Bruijnzeel AW; Kenny PJ; Wright CD; Froestl W; Markou A
    Neuropharmacology; 2005 Dec; 49(7):953-62. PubMed ID: 16005474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic nicotine exposure switches the functional role of mesolimbic dopamine transmission in the processing of nicotine's rewarding and aversive effects.
    Tan H; Bishop SF; Lauzon NM; Sun N; Laviolette SR
    Neuropharmacology; 2009 Mar; 56(4):741-51. PubMed ID: 19133278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine-induced decreases in VTA electrical self-stimulation thresholds: blockade by haloperidol and mecamylamine but not scopolamine or ondansetron.
    Ivanová S; Greenshaw AJ
    Psychopharmacology (Berl); 1997 Nov; 134(2):187-92. PubMed ID: 9399383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facilitation of intracranial self-stimulation behavior in rats by environmental stimuli associated with nicotine.
    Itasaka M; Hanasawa M; Hironaka N; Miyata H; Nakayama K
    Physiol Behav; 2012 Oct; 107(3):277-82. PubMed ID: 22995979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopamine D1/5 and D2/3 agonists differentially attenuate somatic signs of nicotine withdrawal in rats.
    Ohmura Y; Jutkiewicz EM; Zhang A; Domino EF
    Pharmacol Biochem Behav; 2011 Oct; 99(4):552-6. PubMed ID: 21624384
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nicotine potentiation of brain stimulation reward reversed by DH beta E and SCH 23390, but not by eticlopride, LY 314582 or MPEP in rats.
    Harrison AA; Gasparini F; Markou A
    Psychopharmacology (Berl); 2002 Feb; 160(1):56-66. PubMed ID: 11862374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat.
    Cryan JF; Bruijnzeel AW; Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):347-58. PubMed ID: 12698231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse liability assessment of an e-cigarette refill liquid using intracranial self-stimulation and self-administration models in rats.
    LeSage MG; Staley M; Muelken P; Smethells JR; Stepanov I; Vogel RI; Pentel PR; Harris AC
    Drug Alcohol Depend; 2016 Nov; 168():76-88. PubMed ID: 27627814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of repeated withdrawal episodes, nicotine dose, and duration of nicotine exposure on the severity and duration of nicotine withdrawal in rats.
    Skjei KL; Markou A
    Psychopharmacology (Berl); 2003 Jul; 168(3):280-92. PubMed ID: 12712232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist and antagonist effects of cytisine in vivo.
    Radchenko EV; Dravolina OA; Bespalov AY
    Neuropharmacology; 2015 Aug; 95():206-14. PubMed ID: 25839895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of repeated exposure on the reward-enhancing effects of nicotine.
    Barrett ST; Odum AL
    Behav Pharmacol; 2011 Aug; 22(4):283-90. PubMed ID: 21562409
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.